Merck Announces New Agreement with ADAP Crisis Task Force to Improve Access and Care for People Living with HIV 29 June
FDA Approves KEYTRUDA® and KEYTRUDA QLEX , each with Trodelvy® as First-Line Treatment of PD-L1+ Advanced Triple-Negative Breast Cancer 25 June
